Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The percentages reported in this Schedule 13G are based upon 44,873,646 Shares outstanding as of May 2, 2025 (according to the issuer's Form 10-Q as filed with the Securities and Exchange Commission on May 8, 2025).


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



 
PFM Health Sciences, LP
 
Signature:/s/ Darren Mooney
Name/Title:Darren Mooney, Authorized Signatory
Date:08/14/2025
 
PFM Health Sciences GP, LLC
 
Signature:/s/ Darren Mooney
Name/Title:Darren Mooney, Authorized Signatory
Date:08/14/2025
 
Partner Asset Management, LLC
 
Signature:/s/ Darren Mooney
Name/Title:Darren Mooney, Authorized Signatory
Date:08/14/2025
 
Brian D. Grossman
 
Signature:/s/ Darren Mooney
Name/Title:Darren Mooney, attorney-in-fact*
Date:08/14/2025

Comments accompanying signature:  * Darren Mooney is signing on behalf of Brian Grossman as attorney-in-fact pursuant to a power of attorney dated February 1, 2024, and incorporated by reference herein. The power of attorney was filed as an attachment to a filing by certain of the Reporting Persons on Schedule 13G/A for Praxis Precision Medicines, Inc. on February 14, 2024.